3G3E | pdb_00003g3e

Crystal structure of human D-amino acid oxidase in complex with hydroxyquinolin-2(1H)


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.20 Å
  • R-Value Free: 
    0.294 (Depositor), 0.299 (DCC) 
  • R-Value Work: 
    0.239 (Depositor), 0.247 (DCC) 
  • R-Value Observed: 
    0.242 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 3G3E

Ligand Structure Quality Assessment 


This is version 1.2 of the entry. See complete history

Literature

Discovery, SAR, and pharmacokinetics of a novel 3-Hydroxyquinolin-2(1H)-one series of potent D-amino acid oxidase (DAAO) inhibitors

Duplantier, A.J.Becker, S.L.Bohanon, M.J.Borzilleri, K.A.Chrunyk, B.A.Downs, J.T.Hu, L.Y.El-Kattan, A.James, L.C.Liu, S.Lu, J.Maklad, N.Mansour, M.N.Mente, S.Piotrowski, M.A.Sakya, S.M.Sheehan, S.Steyn, S.J.Strick, C.A.Williams, V.A.Zhang, L.

(2009) J Med Chem 52: 3576-3585

  • DOI: https://doi.org/10.1021/jm900128w
  • Primary Citation Related Structures: 
    3G3E

  • PubMed Abstract: 

    3-Hydroxyquinolin-2(1H)-one (2) was discovered by high throughput screening in a functional assay to be a potent inhibitor of human DAAO, and its binding affinity was confirmed in a Biacore assay. Cocrystallization of 2 with the human DAAO enzyme defined the binding site and guided the design of new analogues. The SAR, pharmacokinetics, brain exposure, and effects on cerebellum D-serine are described. Subsequent evaluation against the rat DAAO enzyme revealed a divergent SAR versus the human enzyme and may explain the high exposures of drug necessary to achieve significant changes in rat or mouse cerebellum D-serine.


  • Organizational Affiliation
    • Pfizer Global Research and Development, Groton Laboratories, Groton, CT 06340, USA. allen.j.duplantier@pfizer.com

Macromolecule Content 

  • Total Structure Weight: 163.74 kDa 
  • Atom Count: 11,512 
  • Modeled Residue Count: 1,360 
  • Deposited Residue Count: 1,404 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
D-amino-acid oxidase
A, B, C, D
351Homo sapiensMutation(s): 0 
Gene Names: DAODAMOX
EC: 1.4.3.3
UniProt & NIH Common Fund Data Resources
Find proteins for P14920 (Homo sapiens)
Explore P14920 
Go to UniProtKB:  P14920
PHAROS:  P14920
GTEx:  ENSG00000110887 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP14920
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 2 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
FAD

Query on FAD



Download:Ideal Coordinates CCD File
E [auth A],
G [auth B],
I [auth C],
K [auth D]
FLAVIN-ADENINE DINUCLEOTIDE
C27 H33 N9 O15 P2
VWWQXMAJTJZDQX-UYBVJOGSSA-N
G3E

Query on G3E



Download:Ideal Coordinates CCD File
F [auth A],
H [auth B],
J [auth C],
L [auth D]
3-hydroxyquinolin-2(1H)-one
C9 H7 N O2
BERPCVULMUPOER-UHFFFAOYSA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.20 Å
  • R-Value Free:  0.294 (Depositor), 0.299 (DCC) 
  • R-Value Work:  0.239 (Depositor), 0.247 (DCC) 
  • R-Value Observed: 0.242 (Depositor) 
Space Group: P 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 51.063α = 102.62
b = 82.584β = 105.43
c = 96.974γ = 110.79
Software Package:
Software NamePurpose
REFMACrefinement

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2009-06-23
    Type: Initial release
  • Version 1.1: 2011-07-13
    Changes: Advisory, Version format compliance
  • Version 1.2: 2023-09-06
    Changes: Data collection, Database references, Derived calculations, Refinement description